Recall Z-0679-2020

Roche Diagnostics Operations, Inc. · initiated October 4, 2019

Class II Terminated

Class II – products that might cause a temporary health problem or pose a slight threat of a serious nature

Product

Roche Homocysteine-In vitro test for the quantitative determination of total L-homocysteine in human serum and plasma on Roche/Hitachi cobas c systems Catalog Number: 06542921190 - - Product Usage: The assay can assist in the diagnosis of patients suspected of having hyperhomocysteinemia or homocystinuria.

Codes / lots: Lot Number: 422313 Exp Date: 07/31/2020

Reason for recall

Homocysteine Reagent, Calibration Failures and Quality Control Recovery Issues on cobas c 701 and 702 modules

FDA-determined cause: Device Design

Action taken

The Urgent Medical Device Correction (UMDC) was sent via Roche issued Urgent Medical Device notification via FedEx (signature required) to the consignee list on 10/04/2019. The letter states issue, health risk nd action to take: Discontinue use and discard the remaining affected product in inventory according to local waste guidelines. Because a replacement lot is currently not available, Roche will issue credit for Homocysteine cobas c packs, lot number 422313, remaining in your inventory. If customers have another validated system (i.e. cobas c501/502) in their lab and wish to set up the Roche Homocysteine assay on one of these modules (different catalog number than that subject to this recall), they will be instructed to contact a Roche Field Specialist for support. " A reimbursement for send out testing to an accredited laboratory will also be provided for those customers without another Roche system available. Contact the Roche Support Network Customer Support Center, 24 hours a day, seven days a week at 1-800-428-2336 if you have questions about the information The UMDC will also be posted to the diagnostics.roche.com website.

Details

Recall number
Z-0679-2020
Initiated
October 4, 2019
Terminated
October 9, 2020
Product code
LPS – Urinary Homocystine (Nonquantitative) Test System
Quantity
82 units (US)
Distribution
US Nationwide distribution in the states of NJ, HI, IA.
Recalling firm
Roche Diagnostics Operations, Inc., Indianapolis, IN

Official FDA recall record